Related Experiment Video
Updated: May 3, 2026

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.2K
Mechanisms of asthma
William W Busse1, Lanny J Rosenwasser
1Allergy and Clinical Immunology, University of Wisconsin Department of Medicine, Madison, WI, USA.
The Journal of Allergy and Clinical Immunology
|March 6, 2003
Summary
Investigating airway inflammation in asthma reveals insights into disease severity and persistence. Research highlights the roles of cytokines, chemokines, genetics, and albuterol enantiomers in asthma mechanisms.
Area of Science:
- Immunology
- Pulmonology
- Genetics
Background:
- Airway inflammation is central to asthma pathogenesis.
- Recent research explores novel methods for assessing airway inflammation and its link to asthma severity.
- Understanding the molecular and genetic underpinnings of asthma is crucial for developing targeted therapies.
Purpose of the Study:
- To review recent advancements in understanding asthma mechanisms, focusing on airway inflammation.
- To explore the role of T(H)1/T(H)2 cytokine balance, chemokines, and genetic factors in asthma.
- To evaluate the potential therapeutic advantages of monoisomeric albuterol therapy.
Main Methods:
- Investigative bronchoscopy with segmental antigen challenge and induced sputum analysis.
- Longitudinal study assessing peripheral blood cytokine generation (IFN-gamma and IL-5).
- Evaluation of chemokines, including thymus and activation-regulated chemokine.
- Analysis of genetic factors through epidemiologic, twin, and microarray studies.
Main Results:
- T(H)1/T(H)2 cytokine balance correlates with asthma persistence and severity.
- Chemokines play a role in regulating inflammation and IgE synthesis in asthma.
- Distinct effects of albuterol enantiomers suggest potential for monoisomeric therapy.
- Genetic factors contribute significantly to asthma development and airway remodeling.
Conclusions:
- Airway inflammation, cytokine balance, chemokines, and genetic predisposition are key factors in asthma.
- Further research into these areas may lead to improved diagnostic tools and therapeutic strategies for asthma.
- Monoisomeric albuterol therapy warrants further investigation for potential clinical benefits.
More Related Videos
Related Concept Videos
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
Asthma III: Clinical Manifestations
49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49

